Twist Bioscience offers Gene Fragments, which are high-quality, double-stranded DNA sequences ranging from 300 to 5,000 base pairs in length. These fragments are synthesized using Twist’s proprietary silicon-based DNA synthesis platform, ensuring high precision and rapid turnaround times. Researchers can utilize these gene fragments for various applications, including cloning, gene assembly, and synthetic biology projects. For high-throughput screening applications, Twist provides Multiplexed Gene Fragments (MGFs). These are pools of double-stranded DNA fragments, each up to 500 base pairs long, delivered collectively rather than individually. This format is particularly beneficial for applications such as CRISPR-based functional screening, protein engineering, antibody discovery, and massively parallel reporter assays (MPRA), where handling a large number of variants simultaneously is advantageous. Twist’s gene fragments are designed for compatibility with standard cloning methods and can be customized to meet specific research needs. The company’s advanced synthesis technology results in low error rates, reducing the time and cost associated with downstream applications. With competitive pricing and fast delivery options, Twist’s gene fragments are a valuable resource for accelerating research and development in various fields of molecular biology.